Skinbiotherapeitics

345 days ago

SkinBioTherapeutics – SkinBiotix additional formal studies, a short-term delay but enhanced outlook: STRONG BUY

SkinBioTherapeutics (SBTX) has announced on its AxisBiotix-Ps (psoriasis) product that it has commenced sales in Spain aided by the launch of a regional website and on its skin care active ingredient SkinBiotix that partner, cosmetics business of FTSE-100 Croda (CRDA), Sederma has noted ‘exciting’ additional benefits which means delays in monetisation. Is that good news or bad?

2088 days ago

Tom Winnifrith Bearcast, Jim Mellon, SalvaRx and the lessons from the todger spray episode

In today's delayed podcast I look at the lessons for SalvaRx (SALV) from the Plethora (PLE) & Regent Pacific episode and ask what is happening at Regent as its shares continue to slide? I also look at the increasingly confused picture at Online Blockchain (OBC) and then ponder why CEO's should not be a guide to share prices or when to sell, ref Optibiotx (OPTI), noting also today's events at Skinbiotherapeutics (SBTX)